Skip to NavigationSkip to content


EMA to cut activities as it forecasts loss of 30% of staff

The European Medicines Agency is set to enact temporary cuts in activities as it prepares for significant disruption in the wake of Brexit.

The Agency announced on Wednesday that it now expects to lose 30% of its staff as it makes the move from London to Amsterdam.

While the EMA had previously predicted that around 19% of its staff would leave, the European agency upped the figure by 11% as it revealed that employees who do not want to make the move to the Dutch capital have already begun to depart.

Sanofi join AstraZeneca and MSD in stockpiling medicines, 1800 jobs at risk

French multinational Sanofi have begun stockpiling drugs in preparation for a no-deal Brexit.

The company will join AstraZeneca and MSD in making arrangements to increase its stockpile of medicines in preparation for an abrupt exit from the European Union. The French drug maker is set to increase its supplies to allow for an additional ten weeks of disruption as it seeks to build up 14 weeks’ worth of medical supplies.

Study reveals doctors political views as BMA backs Brexit final say

The London-based British Medical Association (BMA), which represents 156,000 doctors and 19,000 medical students, is supporting calls for a ‘final say’ on the Brexit deal.

The support has come as a study published in the BMA’s academic journal, the BMJ Journal of Epidemiology and Community Health, has revealed that the overwhelming majority of British doctors believe that Brexit will have a substantial negative impact on the NHS.

Army to ferry medicines in case of no-deal Brexit

British army soldier marching

Ministers have established plans to use the army to deliver medicines, food and fuel in the event of a no-deal Brexit.

The Sunday Times has reported that blueprints for procedures used in the case of civil emergencies have been ‘dusted down’ in preparation for a hard Brexit.

In the event of an abrupt exit from the EU, British army trucks and helicopters will be used to transport medical supplies to vulnerable people outside of the southeast of England.

NHS to stockpile drugs in preparation for no-deal Brexit

Matt Hancock

Secretary of State for Health and Social Care, Matt Hancock, has said that the NHS is preparing to stockpile medicines to safeguard against a no-deal Brexit.

While the Conservative party politician said he was confident that a deal would be made, Hancock told the Health Select Committee that he had met with medical industry leaders in order to “accelerate” preparations for a hard Brexit, as he noted that it was “responsible to prepare for all outcomes”.

Top Ten most popular articles on this week

As Brexit negotions have hit a stalemate this week, the United Kingdom's exit from the European Union has hit the headlines. While AstraZeneca have increased their stockpiles in preperation for a no-deal Brexit, the British parliament offered assurance that the UK would retain close ties with the EMA.

MPs vote to stay in EMA after Brexit

British MPs have voted for the UK's continued participation in the regulatory network operated by the European Medicines Agency (EMA) after Brexit.

MPs yesterday voted 305-301 in favour of continued involvement with the EMA after Brexit. The government will now be tasked with securing a deal in which the UK is able to remain an “active participant” in the EMA following the United Kingdom’s exit from the European Union.

AstraZeneca increases drug stockpile in preparation for no-deal Brexit

The Anglo-Swedish drug giant AstraZeneca is set to increase its stockpile of drugs in both the United Kingdom and the European Union in preparation for a hard, no-deal Brexit.

EMA survey identifies gaps in pharma industry's preparedness for Brexit

An EMA survey has identified gaps in the pharmaceutical industry’s preparedness for Brexit, finding that only 58% of market authorisation holders are on track with their regulatory planning in preparation for the UK’s exit from the European Union in March 2019.  

The survey, aimed at identifying centrally authorised products (CAPs) that are at risk of shortages following Brexit, identified that for 16% of the medicines surveyed, there are serious concerns the necessary procedures will not be carried out in time.

Brexit negotiations: Is the public’s health a priority?

Published on 12/06/18 at 11:22am

The Brexit decision has created a huge amount of question marks for many industries and each is vying with each other for the ear of the UK Government. Ben Hargreaves states the case that, for the public’s health, the healthcare and life science industries should be at the front of the queue.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches